Miquel Vila Bover

I am an ICREA Professor and I lead the Research Group on Neurodegenerative Diseases at the Vall d'Hebron Research Institute (VHIR)

Instituciones de las que forman parte

Jefe de grupo
Enfermedades Neurodegenerativas

Vall Hebron Institut de Recerca

Miquel Vila Bover

Instituciones de las que forman parte

Jefe de grupo
Enfermedades Neurodegenerativas

Vall Hebron Institut de Recerca

I am an ICREA Professor and I lead the Research Group on Neurodegenerative Diseases at the Vall d'Hebron Research Institute (VHIR)

I have a degree in Medicine and Surgery from the University of Barcelona (1993) and a PhD in Neuroscience from the University of Paris 6 (1998). My doctoral work carried out in the laboratory of experimental neurology at the Salpetriere Hospital in Paris (1993-98) contributed to establishing the subthalamic nucleus as the main therapeutic target for the surgical treatment of Parkinson's disease with deep brain stimulation. From 1998 to 2005 I worked at the Movement Disorders Unit of Columbia University in New York (USA), initially as a postdoctoral researcher and from 2001 as an Assistant Professor of Neurology, focusing on the study of the mechanisms of neuronal death in Parkinson's disease to identify new therapeutic targets for this currently incurable neurodegenerative disorder.

In 2006 I moved to Barcelona as a Professor at ICREA (Catalan Institute of Research and Advanced Studies) to create and lead a new research group in neurodegenerative diseases at the Vall d'Hebron Research Institute (VHIR). Our group is now part of the Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED) and the Aligning Science Across Parkinson's Collaborative Research Network (ASAP-CRN).

I am also an Associate Professor at the Autonomous University of Barcelona, Principal Investigator at CIBERNED, Coordinating Lead PI at ASAP-CRN and member of the Steering Committees of the World Parkinson Coalition and the Basic Science Special Interest Group of the International Parkinson and Movement Disorder Society.

Proyectos

Rol de la neuromelanina y alfa-sinucleína en el inicio y extensión de la Enfermedad de Parkinson: potencial diagnóstico y terapéutico en nuevos modelos pre-clínicos

IP: Miquel Vila Bover
Colaboradores: Laia Perez Lasarte
Entidad financiadora: Instituto de Salud Carlos III
Financiación: 82400
Referencia: FI14/00613
Duración: 01/01/2015 - 31/12/2018

Disfunción mitocondrial en la enfermedad de Parkinson: papel de la dinámica mitocondrial

IP: Miquel Vila Bover
Colaboradores: Laia Perez Lasarte
Entidad financiadora: Ministerio de Educación, Cultura y Deporte
Financiación: 61544
Referencia: FPU13/01339
Duración: 02/09/2014 - 31/01/2018

Prion-like Dissemination of Synuclein Pathology: A Non-human Study

IP: Miquel Vila Bover
Colaboradores: -
Entidad financiadora: Michael J. Fox Foundation
Financiación: 374375
Referencia: PRIONLIKE_MJFF2013
Duración: 01/01/2014 - 31/12/2016

Transcriptional profiling by Next-Generation Sequencing in pre-symptomatic, early and advanced phases of Parkinson's Disease

IP: Miquel Vila Bover
Colaboradores: Ariadna Laguna Tuset, Laia Perez Lasarte
Entidad financiadora: Agència Gestió Ajuts Universitaris i de Recerca
Financiación: 91022.4
Referencia: 2013 BP_B 00113
Duración: 01/10/2014 - 30/09/2016